Abstract
The Drug Discovery Technology (DDT) Alert is Technical Insights' new
technology research subscription that reports and analyzes the latest
developments in drug discovery and therapeutics, thereby providing an
opportunity to acquire strategic insights into crucial developments in this
industry domain. The alert typically profiles technologies that fall within
the confines of, but are not limited to, technologies used for biomarker and
target discovery such as high-throughput screening, signal transduction, micro
arrays, RNAi, metabolomics, toxicogenomics, biosensors, and nanotechnology. In
addition to these areas, a fair focus is dedicated to the latest trends in
therapeutic approaches across a diversity of diseases including infectious,
genetic, metabolic, neurological, cardiac, and autoimmune disorders. The alert
also analyzes regulatory affairs with respect to drug discovery and
development from time to time. Through a focus on the above mentioned
technologies, the DDT alert lists out important technology developers and
provides appropriate market and end-user intelligence that offers critical and
strategic intelligence to anyone operating or interested in this dynamic
sector. In order to bring to your desk the latest research and updates on the
drug discovery front, our analysts interface directly with primary researchers
to obtain crucial information that is likely to have a significant commercial
impact.
View Cart
